Suchergebnisse - "Ferdinandus, Justin"

PubPharm (56)

1

Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin's lymphoma : an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group

enthalten in: European journal of nuclear medicine and molecular imaging | 2024

von Ferdinandus, J. | van Heek, L. | Roth, K. | +5

2

Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early-stage unfavorable Hodgkin lymphoma : Data from the phase III HD17 trial

enthalten in: European journal of haematology | 2023

von van Heek, L. | Weindler, J. | Gorniak, C. | +11

3

68Ga-Labeled Fibroblast Activation Protein Inhibitor (68Ga-FAPI) PET for Pancreatic Adenocarcinoma : Data from the 68Ga-FAPI PET Observational Trial

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2023

von Kessler, L. | Hirmas, N. | Pabst, K. | +14

4

Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin’s lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Ferdinandus, J. | van Heek, L. | Roth, K. | +5

5

68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment : An International Multicenter Prospective Study

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2023

von Mei, R. | Kessler, L. | Pabst, K. | +19

6

Clinical applications of circulating tumor DNA in Hodgkin lymphoma

enthalten in: Seminars in hematology | 2023

von Heger, J. | Ferdinandus, J. | Mattlener, J. | +1

7

Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification : a post-hoc analysis of the PETAL trial

enthalten in: Leukemia | 2022

von Seifert, R. | Kersting, D. | Rischpler, C. | +13

8

A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma

enthalten in: Seminars in nuclear medicine | 2022

von Sandach, P. | Seifert, R. | Fendler, W. | +6

9

FDG-PET Positivity and Overall Survival in Renal Cell Carcinoma

enthalten in: JAMA network open | 2022

von Ferdinandus, J. | Maríc, I. | Darr, C. | +4

10

Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Fendler, W. | Pabst, K. | Kessler, L. | +15

1
2
3
4
5
6
Nächster »
[6]